Premature atherosclerosis-related central nervous system involvement in two cases of systemic lupus erythematosus

被引:4
作者
Zhang, Xuan
Tian, Xinping
Zhang, Fengchun [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol & Immunol, Beijing 100730, Peoples R China
[2] Peking Union Med Coll, Beijing 100730, Peoples R China
关键词
systemic lupus erythematosus; premature atherosclerosis; central nervous system;
D O I
10.1097/RHU.0b013e318133476d
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with systemic lupus erythematosus are prone to premature atherosclerosis. Though atherosclerosis-related coronary artery disease in young lupus patients has been reported, there are a few reports on related central nervous system (CNS) involvement in systemic lupus erythematosus. It is imperative to differentiate CNS-atherosclerosis from active lupus as aggressive immunosuppressive treatment is often the choice for the latter. Two cases of young lupus patients with transient loss of consciousness and cerebral infarctions are reported, in whom atherosclerosis was considered as the major risk factor. Both were premenopausal young women who had more than 10-year histories of lupus. Besides CNS symptoms, they did not have any sign suggesting lupus flare. Both had hyperlipidemia without family histories, and carotid ultrasound showed bilateral atherosclerotic plaques. Both responded to treatment with statins and antiplatelet agents.
引用
收藏
页码:211 / 212
页数:2
相关论文
共 12 条
[1]   Inflammation: A pivotal link between autoimmune diseases and atherosclerosis [J].
Abou-Raya, Anna ;
Abou-Raya, Suzan .
AUTOIMMUNITY REVIEWS, 2006, 5 (05) :331-337
[2]  
Dong Y, 2001, CHINESE MED J-PEKING, V114, P764
[3]   Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus [J].
Doria, A ;
Shoenfeld, Y ;
Wu, R ;
Gambari, PF ;
Puato, M ;
Ghirardello, A ;
Gilburd, B ;
Corbanese, S ;
Patnaik, M ;
Zampieri, S ;
Peter, JB ;
Favaretto, E ;
Iaccarino, L ;
Sherer, Y ;
Todesco, S ;
Pauletto, P .
ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 (11) :1071-1077
[4]   DYSLIPOPROTEINEMIA IN SYSTEMIC LUPUS-ERYTHEMATOSUS - EFFECT OF CORTICOSTEROIDS [J].
ETTINGER, WH ;
GOLDBERG, AP ;
APPLEBAUMBOWDEN, D ;
HAZZARD, WR .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (03) :503-508
[5]   The role of invariant natural killer T cells in lupus and atherogenesis [J].
Major, Amy S. ;
Singh, Ram R. ;
Joyce, Sebastian ;
Van Kaer, Luc .
IMMUNOLOGIC RESEARCH, 2006, 34 (01) :49-66
[6]   Premature atherosclerosis and acute coronary syndrome in systemic lupus erythematosus [J].
Mattu, A ;
Petrini, J ;
Swencki, S ;
Chaudhari, C ;
Brady, WJ .
AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2005, 23 (05) :696-703
[7]   Premature atherosclerosis in systemic lupus erythematosus [J].
Nikpour, M ;
Urowitz, MB ;
Gladman, DD .
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2005, 31 (02) :329-+
[8]   Premature atherosclerotic disease in systemic lupus erythematosus - role of inflammatory mechanisms [J].
Rhew, EY ;
Ramsey-Goldman, R .
AUTOIMMUNITY REVIEWS, 2006, 5 (02) :101-105
[9]   Systemic lupus erythematosus, atherosclerosis, and autoantibodies [J].
Zampieri, S ;
Iaccarino, L ;
Ghirardello, A ;
Tarricone, E ;
Arienti, S ;
Sarzi-Puttini, P ;
Gambari, P ;
Doria, A .
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 :351-361
[10]  
Zhang X, 1999, Zhonghua Nei Ke Za Zhi, V38, P681